C4 glomerulopathy epidemiology and demographics: Difference between revisions
Norina Usman (talk | contribs) |
Norina Usman (talk | contribs) |
||
(One intermediate revision by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There is not much information available about the incidence and prevalence. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Line 17: | Line 18: | ||
===Gender=== | ===Gender=== | ||
C4 glomerulopathy affects men and women equally. | |||
===Race=== | ===Race=== | ||
There is no racial predilection to C4 glomerulopathy. | There is no racial predilection to C4 glomerulopathy. |
Latest revision as of 06:34, 6 August 2020
C4 glomerulopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
C4 glomerulopathy epidemiology and demographics On the Web |
American Roentgen Ray Society Images of C4 glomerulopathy epidemiology and demographics |
Risk calculators and risk factors for C4 glomerulopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]
Overview
There is not much information available about the incidence and prevalence.
Epidemiology and Demographics
Prevalence
There is not much information available about the prevalence of the disease.
Incidence
There is not much information available about the incidence of the disease.
Age
Patients of all age groups may develop C4 glomerulopathy.
Gender
C4 glomerulopathy affects men and women equally.
Race
There is no racial predilection to C4 glomerulopathy.
Geographic Distribution
C4 glomerulopathy can affect both developed or underdeveloped countries equally.